Suppr超能文献

母体给予OM-85可通过下调IL-33/ILC2轴减轻子代过敏性气道炎症。

Maternal OM-85 administration alleviates offspring allergic airway inflammation by downregulating IL-33/ILC2 axis.

作者信息

Zou Wei, Ma Donghai, Sun Fengfei, Chen Zehu, Chen Ying, Li Xuegang, Chen Meizhu, Lin Minmin, Shi Honglei, Wu Baihe, Chen Lei, Liang Zibin, Liu Jing

机构信息

Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.

Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.

出版信息

Pediatr Allergy Immunol. 2025 Feb;36(2):e70044. doi: 10.1111/pai.70044.

Abstract

BACKGROUND

Type 2 innate lymphoid cells (ILC2s) are essential for maintaining immune regulation and promoting tissue homeostasis in allergic asthma. How the development of gut microbiota on neonatal ILC2s influences allergic airway inflammation remains unclear. Here we focus on offspring ILC2 development in the context of alterations in maternal gut microbiota.

METHODS

C57BL/6 maternal mice were gavaged with OM-85 during pregnancy and/or lactation, ILC2-driven allergic airway inflammation in the OVA-sensitized adult offspring was observed. ILC2 development in offspring early life were investigated using recombinant (r)IL-33, rIL-25 and Bromodeoxyuridine in the vivo experiments. Further ILC2 promoting factors- IL-33 and IL-25 production in offspring early life were analysed. Finally, we examined the changes in gut microbiota and its metabolites in both dams and pups, and explored the effects of short-chain fatty acids (SCFAs) on IL-33 expression and secretion.

RESULTS

Maternal OM-85 administration restrained ILC2-driven allergic airway inflammation in the OVA-sensitized adult offspring. During ILC2 development in offspring early life, maternal OM-85 administration suppressed IL-33 and IL-25 production to inhibit ILC2 expansion and ILC2 responsiveness to alarmins, and infantile ILC2s could persist into adulthood. Maternal OM-85 administration increased SCFAs in breast milk and SCFA-producing gut probiotics (predominant Bacteroides and Blautia) in offspring, especially during pregnancy and lactation. SCFAs down-regulated IL-33 expression and reduced IL-33 secretion by inhibited gasdermin D (GSDMD) formation.

CONCLUSION

Maternal OM-85 administration restrains ILC2-driven allergic airway inflammation in adult offspring by increasing offspring intestinal SCFAs to modulate ILC2 development at an early stage, demonstrating that the transgenerational effects of maternal OM-85 exposure on offspring innate immunity.

摘要

背景

2型固有淋巴细胞(ILC2s)对于维持免疫调节和促进过敏性哮喘中的组织稳态至关重要。新生儿ILC2s上肠道微生物群的发育如何影响过敏性气道炎症仍不清楚。在此,我们聚焦于母体肠道微生物群改变背景下子代ILC2的发育。

方法

在妊娠和/或哺乳期给C57BL/6母鼠灌胃OM-85,观察卵清蛋白致敏成年子代中ILC2驱动的过敏性气道炎症。在体内实验中使用重组(r)IL-33、rIL-25和溴脱氧尿苷研究子代早期生命中ILC2的发育。进一步分析子代早期生命中ILC2促进因子——IL-33和IL-25的产生。最后,我们检测了母鼠和幼崽肠道微生物群及其代谢产物的变化,并探讨了短链脂肪酸(SCFAs)对IL-33表达和分泌的影响。

结果

母体给予OM-85可抑制卵清蛋白致敏成年子代中ILC2驱动的过敏性气道炎症。在子代早期生命的ILC2发育过程中,母体给予OM-85可抑制IL-33和IL-25的产生,以抑制ILC2的扩增和ILC2对警报素的反应性,并且婴儿期ILC2s可持续到成年期。母体给予OM-85可增加母乳中的SCFAs以及子代中产生SCFA的肠道益生菌(主要是拟杆菌属和布劳特氏菌属),尤其是在妊娠和哺乳期。SCFAs通过抑制gasdermin D(GSDMD)形成下调IL-33表达并减少IL-33分泌。

结论

母体给予OM-85通过增加子代肠道SCFAs来调节早期ILC2发育,从而抑制成年子代中ILC2驱动的过敏性气道炎症,表明母体暴露于OM-85对子代固有免疫的跨代影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验